Ishikawa M, Yoshitomi T, Covey D, Zorumski C, Izumi Y. Additive neuroprotective effects of 24(S)-hydroxycholesterol and allopregnanolone in an ex vivo rat glaucoma model. Sci Rep. 2018;8:12851 pubmed publisher

Scalas D, Mandras N, Roana J, Tardugno R, Cuffini A, Ghisetti V, et al. Use of Pinus sylvestris L. (Pinaceae), Origanum vulgare L. (Lamiaceae), and Thymus vulgaris L. (Lamiaceae) essential oils and their main components to enhance itraconazole activity against azole susceptible/not-susceptible Cryptococcus neoformans str. BMC Complement Altern Med. 2018;18:143 pubmed publisher

Hu Y, Yu A, Chen X, Wang G, Feng X. Molecular Characterization of Candida africana in Genital Specimens in Shanghai, China. Biomed Res Int. 2015;2015:185387 pubmed publisher

Shrestha S, Fosso M, Garneau Tsodikova S. A combination approach to treating fungal infections. Sci Rep. 2015;5:17070 pubmed publisher

Wang T, Xie J, Wang Y, Zheng X, Lei J, Wang X, et al. Pharmacokinetic and Pharmacodynamic Properties of Oral Voriconazole in Patients with Invasive Fungal Infections. Pharmacotherapy. 2015;35:797-804 pubmed publisher

Bergamo V, Balbueno E, Hatwig C, Pippi B, Dalla Lana D, Donato R, et al. 1-n-Hexadecyl-3-methylimidazolium methanesulfonate and chloride salts with effective activities against Candida tropicalis biofilms. Lett Appl Microbiol. 2015;61:504-10 pubmed publisher

Brannelly L, Skerratt L, Berger L. Treatment trial of clinically ill corroboree frogs with chytridiomycosis with two triazole antifungals and electrolyte therapy. Vet Res Commun. 2015;39:179-87 pubmed publisher

Unterholzner S, Rozhon W, Papacek M, Ciomas J, Lange T, Kugler K, et al. Brassinosteroids Are Master Regulators of Gibberellin Biosynthesis in Arabidopsis. Plant Cell. 2015;27:2261-72 pubmed publisher

Irimie M, Oantă A, Irimie C, Minea D. Prevalence and antifungal susceptibility patterns of dermatophytes isolated from patients with neoplastic diseases: a case control study. Acta Dermatovenerol Croat. 2015;23:108-13 pubmed

Feng X, Ling B, Yang X, Liao W, Pan W, Yao Z. Molecular Identification of Candida Species Isolated from Onychomycosis in Shanghai, China. Mycopathologia. 2015;180:365-71 pubmed publisher

Lamoth F, Alexander B. Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds. J Clin Microbiol. 2015;53:3176-81 pubmed publisher

Yazdanparast S, Khodavaisy S, Fakhim H, Shokohi T, Haghani I, Nabili M, et al. Molecular Characterization of Highly Susceptible Candida africana from Vulvovaginal Candidiasis. Mycopathologia. 2015;180:317-23 pubmed publisher

da Silva B, Silva L, de Oliveira D, da Silva P, Ferreira Paim K, Andrade Silva L, et al. Species Distribution, Virulence Factors, and Antifungal Susceptibility Among Candida parapsilosis Complex Isolates Recovered from Clinical Specimens. Mycopathologia. 2015;180:333-43 pubmed publisher

Niece K, Boyd N, Akers K. In vitro study of the variable effects of proton pump inhibitors on voriconazole. Antimicrob Agents Chemother. 2015;59:5548-54 pubmed publisher

Blooi M, Pasmans F, Rouffaer L, Haesebrouck F, Vercammen F, Martel A. Successful treatment of Batrachochytrium salamandrivorans infections in salamanders requires synergy between voriconazole, polymyxin E and temperature. Sci Rep. 2015;5:11788 pubmed publisher

Bühler N, Hagiwara D, Takeshita N. Functional Analysis of Sterol Transporter Orthologues in the Filamentous Fungus Aspergillus nidulans. Eukaryot Cell. 2015;14:908-21 pubmed publisher

Marty A, Broman A, Zarnowski R, Dwyer T, Bond L, Lounès Hadj Sahraoui A, et al. Fungal Morphology, Iron Homeostasis, and Lipid Metabolism Regulated by a GATA Transcription Factor in Blastomyces dermatitidis. PLoS Pathog. 2015;11:e1004959 pubmed publisher

Mor V, Rella A, Farnoud A, Singh A, Munshi M, Bryan A, et al. Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids. MBio. 2015;6:e00647 pubmed publisher

Samalidou M, Bougiouklis D, Vyzantiadis T, Meletiadis J, Monokrousos N, Siotou E, et al. In vitro and in vivo study on the effect of antifungal agents on hematopoietic cells in mice. Exp Biol Med (Maywood). 2015;240:1728-34 pubmed publisher

Caggiano G, Coretti C, Bartolomeo N, Lovero G, De Giglio O, Montagna M. Candida Bloodstream Infections in Italy: Changing Epidemiology during 16 Years of Surveillance. Biomed Res Int. 2015;2015:256580 pubmed publisher

Matos T, Cerar T, Praprotnik M, Krivec U, Pirs M. First recovery of Rasamsonia argillacea species complex isolated in adolescent patient with cystic fibrosis in Slovenia--case report and review of literature. Mycoses. 2015;58:506-10 pubmed publisher

Mirkov I, Demenesku J, Popov Aleksandrov A, Ninkov M, Glamoclija J, Kataranovski D, et al. Strain differences in the immune mechanisms of resistance of immunocompetent rats to pulmonary aspergillosis. Immunobiology. 2015;220:1075-84 pubmed publisher

Chung H, Lee H, Han H, An H, Lim K, Lee Y, et al. A pharmacokinetic comparison of two voriconazole formulations and the effect of CYP2C19 polymorphism on their pharmacokinetic profiles. Drug Des Devel Ther. 2015;9:2609-16 pubmed publisher

Vanstraelen K, Maertens J, Augustijns P, Lagrou K, de Loor H, Mols R, et al. Investigation of Saliva as an Alternative to Plasma Monitoring of Voriconazole. Clin Pharmacokinet. 2015;54:1151-60 pubmed publisher

Siopi M, Siafakas N, Vourli S, Zerva L, Meletiadis J. Optimization of polyene-azole combination therapy against aspergillosis using an in vitro pharmacokinetic-pharmacodynamic model. Antimicrob Agents Chemother. 2015;59:3973-83 pubmed publisher

Steere B, Baker J, Hall S, Guo Y. Prediction of in vivo clearance and associated variability of CYP2C19 substrates by genotypes in populations utilizing a pharmacogenetics-based mechanistic model. Drug Metab Dispos. 2015;43:870-83 pubmed publisher

Gentry J, Montgerard C, Crandall E, Cruz Espindola C, Boothe D, Bellah J. Voriconazole Disposition After Single and Multiple, Oral Doses in Healthy, Adult Red-tailed Hawks ( Buteo jamaicensis ). J Avian Med Surg. 2014;28:201-8 pubmed publisher

Li X, Cai Q, Mei H, Zhou X, Shen Y, Li D, et al. The Rpd3/Hda1 family of histone deacetylases regulates azole resistance in Candida albicans. J Antimicrob Chemother. 2015;70:1993-2003 pubmed publisher

Kathuria S, Singh P, Sharma C, Prakash A, Masih A, Kumar A, et al. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek . J Clin Microbiol. 2015;53:1823-30 pubmed publisher

Zhang C, Kong Q, Cai Z, Liu F, Chen P, Song J, et al. The newly nonsporulated characterization of an Aspergillus fumigatus isolate from an immunocompetent patient and its clinic indication. Fungal Genet Biol. 2015;81:250-60 pubmed publisher

Matson K, Shaffer C, Beck G, Simonsen K. Assessment of initial serum vancomycin trough concentrations and their association with initial empirical weight-based vancomycin dosing and development of nephrotoxicity in children: a multicenter retrospective study. Pharmacotherapy. 2015;35:337-43 pubmed publisher

Liu J, Shi C, Wang Y, Li W, Zhao Y, Xiang M. Mechanisms of azole resistance in Candida albicans clinical isolates from Shanghai, China. Res Microbiol. 2015;166:153-61 pubmed publisher

Martín Navarro C, López Arencibia A, Sifaoui I, Reyes Batlle M, Valladares B, Martínez Carretero E, et al. Statins and voriconazole induce programmed cell death in Acanthamoeba castellanii. Antimicrob Agents Chemother. 2015;59:2817-24 pubmed publisher

Carolina Rojas O, Leon Cachon R, Pérez Maya A, Aguirre Garza M, Moreno Treviño M, Gonzalez G. Phenotypic and molecular identification of Fonsecaea pedrosoi strains isolated from chromoblastomycosis patients in Mexico and Venezuela. Mycoses. 2015;58:267-72 pubmed publisher

Dong D, Li Z, Zhang L, Jiang C, Mao E, Wang X, et al. Clinical and microbiological investigation of fungemia from four hospitals in China. Mycopathologia. 2015;179:407-14 pubmed publisher

Lemetayer J, Dowling P, Taylor S, Papich M. Pharmacokinetics and distribution of voriconazole in body fluids of dogs after repeated oral dosing. J Vet Pharmacol Ther. 2015;38:451-6 pubmed publisher

Naito T, Yamada T, Mino Y, Kawakami J. Impact of inflammation and concomitant glucocorticoid administration on plasma concentration of triazole antifungals in immunocompromised patients. Clin Chim Acta. 2015;441:127-32 pubmed publisher

Al Hatmi A, Van Diepeningen A, Curfs Breuker I, de Hoog G, Meis J. Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex. J Antimicrob Chemother. 2015;70:1068-71 pubmed publisher

Trabasso P, Matsuzawa T, Fagnani R, Muraosa Y, Tominaga K, Resende M, et al. Isolation and drug susceptibility of Candida parapsilosis sensu lato and other species of C. parapsilosis complex from patients with blood stream infections and proposal of a novel LAMP identification method for the species. Mycopathologia. 2015;179:53-62 pubmed publisher

Xiao M, Fan X, Chen S, Wang H, Sun Z, Liao K, et al. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance. J Antimicrob Chemother. 2015;70:802-10 pubmed publisher

Mori M, Kobayashi R, Kato K, Maeda N, Fukushima K, Goto H, et al. Pharmacokinetics and safety of voriconazole intravenous-to-oral switch regimens in immunocompromised Japanese pediatric patients. Antimicrob Agents Chemother. 2015;59:1004-13 pubmed publisher

Koehling H, Willinger B, Buer J, Rath P, Steinmann J. Comparative evaluation of a new commercial colorimetric microdilution assay (SensiQuattro Candida EU) with MIC test strip and EUCAST broth microdilution methods for susceptibility testing of invasive Candida isolates. J Clin Microbiol. 2015;53:255-61 pubmed publisher

Chung D, Barker B, Carey C, Merriman B, Werner E, Lechner B, et al. ChIP-seq and in vivo transcriptome analyses of the Aspergillus fumigatus SREBP SrbA reveals a new regulator of the fungal hypoxia response and virulence. PLoS Pathog. 2014;10:e1004487 pubmed publisher

Hu Y, Huang X, Lu S, Hamblin M, Mylonakis E, Zhang J, et al. Photodynamic therapy combined with terbinafine against chromoblastomycosis and the effect of PDT on Fonsecaea monophora in vitro. Mycopathologia. 2015;179:103-9 pubmed publisher

Hu L, Du X, Li T, Song Y, Zai S, Hu X, et al. Genetic and phenotypic characterization of Candida albicans strains isolated from infectious disease patients in Shanghai. J Med Microbiol. 2015;64:74-83 pubmed publisher

McMullen R, Gilger B, Michau T. Modified lamellar keratoplasties for the treatment of deep stromal abscesses in horses. Vet Ophthalmol. 2015;18:393-403 pubmed publisher

Kimakura M, Usui T, Yokoo S, Nakagawa S, Yamagami S, Amano S. Toxicity of topical antifungal agents to stratified human cultivated corneal epithelial sheets. J Ocul Pharmacol Ther. 2014;30:810-4 pubmed publisher

Chowdhary A, Kathuria S, Singh P, Sharma B, Dolatabadi S, Hagen F, et al. Molecular characterization and in vitro antifungal susceptibility of 80 clinical isolates of mucormycetes in Delhi, India. Mycoses. 2014;57 Suppl 3:97-107 pubmed publisher

Minea B, Năstasă V, Moraru R, Kolecka A, Flonta M, Marincu I, et al. Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study. Eur J Clin Microbiol Infect Dis. 2015;34:367-83 pubmed publisher

Warrilow A, Hull C, Parker J, Garvey E, Hoekstra W, Moore W, et al. The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme. Antimicrob Agents Chemother. 2014;58:7121-7 pubmed publisher

Brilhante R, de Jesus Santos Rodrigues T, de Souza Collares Maia Castelo Branco D, Teixeira C, de Brito Macedo R, Bandeira S, et al. Antifungal susceptibility and virulence attributes of animal-derived isolates of Candida parapsilosis complex. J Med Microbiol. 2014;63:1568-72 pubmed publisher

Vanstraelen K, Wauters J, Vercammen I, de Loor H, Maertens J, Lagrou K, et al. Impact of hypoalbuminemia on voriconazole pharmacokinetics in critically ill adult patients. Antimicrob Agents Chemother. 2014;58:6782-9 pubmed publisher

Ramos L, Figueiredo Carvalho M, Barbedo L, Ziccardi M, Chaves A, Zancope Oliveira R, et al. Candida haemulonii complex: species identification and antifungal susceptibility profiles of clinical isolates from Brazil. J Antimicrob Chemother. 2015;70:111-5 pubmed publisher

Hempstead J, Clode A, Borst L, Gilger B. Histopathological features of equine superficial, nonhealing, corneal ulcers. Vet Ophthalmol. 2014;17 Suppl 1:46-52 pubmed

Sugui J, Peterson S, Figat A, Hansen B, Samson R, Mellado E, et al. Genetic relatedness versus biological compatibility between Aspergillus fumigatus and related species. J Clin Microbiol. 2014;52:3707-21 pubmed publisher

Negri C, Gonçalves S, Xafranski H, Bergamasco M, Aquino V, Castro P, et al. Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles. J Clin Microbiol. 2014;52:3633-40 pubmed publisher

Piorkowska E, Kaza M, Fitatiuk J, Szlaska I, Pawinski T, Rudzki P. Rapid and simplified HPLC-UV method with on-line wavelengths switching for determination of capecitabine in human plasma. Pharmazie. 2014;69:500-5 pubmed

Zych B, García Sáez D, Sabashnikov A, De Robertis F, Amrani M, Bahrami T, et al. Lung transplantation from donors outside standard acceptability criteria--are they really marginal?. Transpl Int. 2014;27:1183-91 pubmed publisher

Yang Y, Chen M, Gu J, Zhu F, Xu X, Zhang C, et al. Cryptococcosis in kidney transplant recipients in a Chinese university hospital and a review of published cases. Int J Infect Dis. 2014;26:154-61 pubmed publisher

Park C, Lee H, Chung S. Toxicity of intrastromal voriconazole injection on corneal endothelium in rabbits. Cornea. 2014;33:928-34 pubmed publisher

Chowdhary A, Sharma C, van den Boom M, Yntema J, Hagen F, Verweij P, et al. Multi-azole-resistant Aspergillus fumigatus in the environment in Tanzania. J Antimicrob Chemother. 2014;69:2979-83 pubmed publisher

Astvad K, Jensen R, Hassan T, Mathiasen E, Thomsen G, Pedersen U, et al. First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment. Antimicrob Agents Chemother. 2014;58:5096-101 pubmed publisher

Wang Z, Huang C, Sun W, Xiao C, Wang Z. UPLC-MS/MS determination of voriconazole in human plasma and its application to a pharmacokinetic study. Biomed Chromatogr. 2015;29:188-93 pubmed publisher

Sunada A, Kimura K, Nishi I, Toyokawa M, Ueda A, Sakata T, et al. In vitro evaluations of topical agents to treat Acanthamoeba keratitis. Ophthalmology. 2014;121:2059-65 pubmed publisher

Whaley S, Caudle K, Vermitsky J, Chadwick S, Toner G, Barker K, et al. UPC2A is required for high-level azole antifungal resistance in Candida glabrata. Antimicrob Agents Chemother. 2014;58:4543-54 pubmed publisher

Tortorano A, Prigitano A, Esposto M, Arsic Arsenijevic V, Kolarovic J, Ivanovic D, et al. European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe. Eur J Clin Microbiol Infect Dis. 2014;33:1623-30 pubmed publisher

Layer N, Cevallos V, Maxwell A, Hoover C, Keenan J, Jeng B. Efficacy and safety of antifungal additives in Optisol-GS corneal storage medium. JAMA Ophthalmol. 2014;132:832-7 pubmed publisher

Sun C, Lalitha P, Prajna N, Karpagam R, Geetha M, O Brien K, et al. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis. Ophthalmology. 2014;121:1495-500.e1 pubmed publisher

Cordeiro R, Macedo R, Teixeira C, Marques F, Bandeira T, Moreira J, et al. The calcineurin inhibitor cyclosporin A exhibits synergism with antifungals against Candida parapsilosis species complex. J Med Microbiol. 2014;63:936-944 pubmed publisher

Sharma C, Muralidhar S, Xu J, Meis J, Chowdhary A. Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi, India. Mycoses. 2014;57:544-52 pubmed publisher

Bustamante B, Martins M, Bonfietti L, Szeszs M, Jacobs J, Garcia C, et al. Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru. J Med Microbiol. 2014;63:855-860 pubmed publisher

Mistretta V, Dubois N, Denooz R, Charlier C. Simultaneous determination of seven azole antifungal drugs in serum by ultra-high pressure liquid chromatography and diode array detection. Acta Clin Belg. 2014;69:53-61 pubmed publisher

Siopi M, Mavridou E, Mouton J, Verweij P, Zerva L, Meletiadis J. Susceptibility breakpoints and target values for therapeutic drug monitoring of voriconazole and Aspergillus fumigatus in an in vitro pharmacokinetic/pharmacodynamic model. J Antimicrob Chemother. 2014;69:1611-9 pubmed publisher

Chen Y, Yu S, Huang H, Chang Y, Lehman V, Silao F, et al. Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis. Eukaryot Cell. 2014;13:844-54 pubmed publisher

Nagano D, Araki T, Nakamura T, Yamamoto K. Determination of intracellular darunavir by liquid chromatography coupled with fluorescence detection. J Chromatogr Sci. 2014;52:1021-5 pubmed publisher

Alothman A, Al Musawi T, Al Abdely H, Salman J, Almaslamani M, Yared N, et al. Clinical practice guidelines for the management of invasive Candida infections in adults in the Middle East region: Expert panel recommendations. J Infect Public Health. 2014;7:6-19 pubmed publisher

Alvarez Rueda N, Fleury A, Morio F, Pagniez F, Gastinel L, Le Pape P. Amino acid substitutions at the major insertion loop of Candida albicans sterol 14alpha-demethylase are involved in fluconazole resistance. PLoS ONE. 2011;6:e21239 pubmed publisher